Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

• Status: Completed
• Trial end date: 2008-04-01

Summary

This study wants to assess different intensive therapy sequences for the treatment of non-small-cell lung cancer.

It claims less on the efficacy of different chemotherapy combinations, than more on the comparison of different strategies of sequential single-agent, sequential double-agent or sequential triple-agent therapy.

• Phase: Phase 3

Details

• Lead Sponsor: Aktion Bronchialkarzinom e.V.
• Treatments: Carboplatin; Gemcitabine; Ifosfamide; Mitomycin; Mitomycins; Vinorelbine